-transparent.png){kind=logo}
Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci. 1996
Department of Pathology (Clinical Microbiology), Case Western Reserve University, Cleveland, Ohio 44106, USA.
Microdilution MIC testing was used to test the susceptibility of 202 pneumococci to LY 333328 and six other agents. LY 333328 was the most active glycopeptide (MIC at which 90% of the pneumococci were inhibited [MIC90], 0.008 microgram/ml), followed by teicoplanin (MIC90, 0.06 microgram/ml) and vancomycin (MIC90, 0.5 microgram/ml). Rifampin resistance was seen in some penicillin-resistant strains. The MICs of imipenem and ceftriaxone rose with those of penicillin. Time-kill testing confirmed the excellent antipneumococcal activity of LY 333328.
Related Publications
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
August 1996,
Antimicrobial agents and chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
July 1995,
Antimicrobial agents and chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
May 1995,
Antimicrobial agents and chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
December 1993,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
June 1995,
The Journal of antimicrobial chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
April 2000,
Antimicrobial agents and chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
October 1998,
The Journal of antimicrobial chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
June 2003,
Antimicrobial agents and chemotherapy,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
July 2000,
Chinese medical journal,
E Fasola, and
S K Spangler, and
L M Ednie, and
M R Jacobs, and
S Bajaksouzian, and
P C Appelbaum
January 2007,
Pharmazie in unserer Zeit,
